Jump to main content

博士論文

MCL1 inhibition enhances the therapeutic effect of MEK inhibitors in KRAS-mutant lung adenocarcinoma cells.

Icons representing 博士論文
The cover of this title could differ from library to library.

Available in National Diet Library

Find on the publisher's website

NDL Digital Collections

Digital data available

Check on the publisher's website

MCL1 inhibition enhances the therapeutic effect of MEK inhibitors in KRAS-mutant lung adenocarcinoma cells.

Persistent ID (NDL)
info:ndljp/pid/11679782
Material type
博士論文
Author
多田, 周
Publisher
-
Date granted
2019-09-30
Material Format
Digital
Capacity, size, etc.
-
Degree grantor and degree
札幌医科大学,博士（医学）
View All

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii ResearchLeave the NDL website. から、本文を自由に閲覧できる場合があります。

Notes on use

Note (General)：

出版タイプ： VoR

Search by Bookstore

Search by Bookstore

Read this material in an accessible format.

View materials in accessible formats for people with print disabilities (1Type)

Table of Contents

Provided by：国立国会図書館デジタルコレクション

  • 2025-07-04 再収集

Search by Bookstore

Read in Disability Resources

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Title
MCL1 inhibition enhances the therapeutic effect of MEK inhibitors in KRAS-mutant lung adenocarcinoma cells.
Author/Editor
多田, 周
Author Heading
多田, 周
Publication Date
2019-09-30
Publication Date (W3CDTF)
2019-09-30
Alternative Title
MCL1阻害はKRAS変異陽性肺腺癌におけるMEK阻害薬の治療効果を高める
Degree Grantor
札幌医科大学
Date Granted
2019-09-30
Date Granted (W3CDTF)
2019-09-30